Global Fund Commits N1.16 Trillion to Combat HIV, TB, and Malaria in Nigeria
Global Fund Allocates N1.16tr for HIV, TB, Malaria in Nigeria

Global Fund Allocates N1.16 Trillion for HIV, TB, and Malaria in Nigeria

The Global Fund has announced a significant allocation of approximately N1.16 trillion, equivalent to $790 million, to support Nigeria's efforts in combating HIV, tuberculosis (TB), malaria, and strengthening health systems for the implementation period spanning 2027 to 2029. This funding aims to bolster the country's healthcare infrastructure and enhance disease control initiatives.

Call for Sustainable Domestic Funding

In a critical appeal, the Global Fund has urged the Nigerian government to ensure uninterrupted funding for tuberculosis programs. The organization warned that without adequate domestic financial support, Nigeria risks reversing the substantial progress made in the fight against TB, an infectious disease that remains a major public health concern. Emphasizing the importance of sustained investment, the Global Fund highlighted that with continued innovation and strengthened healthcare systems, Nigeria has the potential to eliminate TB as a significant health threat.

Federal Government's Role and Commitments

According to reports, the Federal Government is expected to provide 15 per cent counterpart funding in addition to the GC7 co-financing commitments. This collaborative financial approach is designed to ensure the effective utilization of the allocated resources and support long-term sustainability in health interventions.

Wide Pickt banner — collaborative shopping lists app for Telegram, phone mockup with grocery list

Remarks from Global Fund and Health Officials

Jean-Thomas Nouboussi, the Global Fund Team Lead in Nigeria, made these statements during the official launch of Lenacapavir (LEN) PrEP for HIV prevention and the unveiling of the Multisectoral Accountability Framework for TB (MAF-TB) application in Abuja. Nouboussi praised Nigeria's impressive achievements in TB control, noting that treatment coverage increased dramatically from 100,000 cases in 2019 to 458,000 cases in 2025. He described Lenacapavir as a game-changer in HIV prevention, addressing key challenges such as adherence to daily regimens.

In his remarks, Dr. Adekunle Salako, the Minister of State for Health and Social Welfare, highlighted a historic milestone in Nigeria's TB response. He reported that case notifications surged from 130,591 in 2020 to 440,000 in 2025, the highest ever recorded in the country. Salako attributed this success to the strategic expansion of diagnostic networks, particularly the gene expert network, which has improved detection and treatment outcomes.

Implications for Public Health

This substantial funding allocation and the call for sustainable domestic support underscore the critical need for ongoing investment in Nigeria's healthcare sector. By addressing funding gaps and enhancing health systems, Nigeria can build on its recent successes and move closer to ending HIV, TB, and malaria as public health emergencies.

Pickt after-article banner — collaborative shopping lists app with family illustration